Mynzepli 40 mg/ml

Mynzepli 40 mg/ml is a medicine authorised by Swissmedic under authorisation number 70617. The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 13 May 2026 and the authorisation is limited until 12 May 2031. ATC code S01LA05 places the medicine in the group Ophthalmologicals.

  • Dispensing category B
  • Authorisation number 70617
  • ATC S01LA05
  • Biotechnological medicines
Authorisation data
Authorisation number70617
NameMynzepli 40 mg/ml
Full nameMynzepli 40 mg/ml, Injektionslösung in einer Fertigspritze
Authorisation holderAdvanz Pharma Specialty Medicine Switzerland GmbH
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeS01LA05
First authorisation13 May 2026
Authorisation validity12 May 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Mynzepli 40 mg/ml, Injektionslösung in einer FertigspritzeB13 May 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
11Fertigspritze(n)S01LA0511.99.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Mynzepli 40 mg/ml authorised in Switzerland?

Yes. Mynzepli 40 mg/ml is authorised by Swissmedic under authorisation number 70617, data as of 01 September 2026. The authorisation is limited until 12 May 2031.

Which dispensing category does Mynzepli 40 mg/ml have?

Mynzepli 40 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Mynzepli 40 mg/ml?

The authorisation holder is Advanz Pharma Specialty Medicine Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com